Map Study I: Large Blue Circle - ON SALE

by American Printing House for the Blind

$3.50

Professional guidance helps This is a replacement part for a structured tactile mapping curriculum typically used by Teachers of the Visually Impaired (TVIs). While the piece itself is simple, effective use requires a professional to embed it back into the pedagogical context of the Map Study 1 program.

Last verified June 15, 2026 · classified May 14, 2026

What it is

Summary

AI-generated from vendor-published content · May 14, 2026

This is a single replacement component — a large blue circle — from APH's Maps Represent Real Places: Map Study 1 tactile mapping curriculum. Tactile map study kits use raised shapes and textures to teach students with visual impairments how maps work as spatial representations of real places. This piece is only useful if you already own the Map Study 1 kit and need to replace a lost or damaged component; it has no standalone function. Note that this product has been discontinued by APH, so availability is limited to remaining stock.

Quick Facts Catalog facts · auto-generated
Age range
ComplexityProfessional guidance helps
Price$3.50
Funding
  • Out of pocket
  • School district
VerifiedJune 15, 2026
ClassifiedMay 14, 2026 · confidence: high

What Setup Looks Like

  • Out of the box
    Locate the corresponding activity in the Map Study 1 kit and reintroduce the replacement circle into that lesson material.

Getting it

Many states lend devices like this for free trial periods — find your state's AT lending program.

Where to Get It

aph Visit
$3.50

Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →

Wondering how equipment like this gets paid for? See the official funding programs in your state.

Sources & fine print

Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blindview on vendor site; last verified June 15, 2026.

Classification & description AI-generated from vendor-published content on May 14, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.